Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 Nov;69(5):579–583. doi: 10.1136/jnnp.69.5.579

Paradox of a better test for Huntington's disease

A Maat-Kievit 1, M Vlis 1, M Zoeteweij 1, M Losekoot 1, A van Haeringen 1, R Roos 1
PMCID: PMC1763393  PMID: 11032607

Abstract

OBJECTIVES—To describe the consequences of the identification of the Huntington's disease (HD) mutation on predictive and prenatal testing.
METHODS—A retrospective study was performed considering the test applicants, procedures, and results before and after the identification of the mutation. 1032 people at risk for Huntington's disease in The Netherlands were included, of whom 741 applied for the predictive test in the period 1987 to 1997 in Leiden at the Department of Clinical Genetics, and after 1994, also in the other seven clinical genetics departments in The Netherlands. Uptake, sociodemographic variables, and test results, taken before and after the mutation was identified, are described.
RESULTS—The uptake of the predictive test in the period studied was 24% and for the prenatal test 2%. No differences were noted in numbers and sociodemographic data between the period before and after the mutation was identified. After an initial increase in test applicants, a decrease was seen after 1995. After 1993 a significant increase of 25% at risk test applicants and a significant decrease of prenatal exclusion tests was noticed. Only 7% asked for reassessment by mutation analysis. New problems arose after the identification of the mutation, such as the option of reassessing the risk obtained by linkage analysis, direct mutation testing of 25% at risk persons with a parent who does not wish to know, new choices regarding reproduction, and new uncertainties for carriers of intermediate and reduced penetrance alleles and for their offspring and relatives.
CONCLUSIONS—Although predictive testing has become reliable and available for every person at risk since the mutation has been identified, the uptake of predictive and prenatal tests fell short of expectation, no change in sociodemographic variables was seen, and a decrease in number of applicants was noted. Furthermore, new uncertainties, psychological problems, and questions arose.



Full Text

The Full Text of this article is available as a PDF (126.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almqvist E. W., Bloch M., Brinkman R., Craufurd D., Hayden M. R. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet. 1999 May;64(5):1293–1304. doi: 10.1086/302374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benjamin C. M., Adam S., Wiggins S., Theilmann J. L., Copley T. T., Bloch M., Squitieri F., McKellin W., Cox S., Brown S. A. Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet. 1994 Oct;55(4):606–617. [PMC free article] [PubMed] [Google Scholar]
  3. Bloch M., Fahy M., Fox S., Hayden M. R. Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet. 1989 Feb;32(2):217–224. doi: 10.1002/ajmg.1320320215. [DOI] [PubMed] [Google Scholar]
  4. Codori A. M., Hanson R., Brandt J. Self-selection in predictive testing for Huntington's disease. Am J Med Genet. 1994 Sep 15;54(3):167–173. doi: 10.1002/ajmg.1320540303. [DOI] [PubMed] [Google Scholar]
  5. Conneally P. M. Huntington disease: genetics and epidemiology. Am J Hum Genet. 1984 May;36(3):506–526. [PMC free article] [PubMed] [Google Scholar]
  6. Evers-Kiebooms G., Cassiman J. J., van den Berghe H. Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium. J Med Genet. 1987 May;24(5):275–279. doi: 10.1136/jmg.24.5.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  8. Harper P. S., Newcombe R. G. Age at onset and life table risks in genetic counselling for Huntington's disease. J Med Genet. 1992 Apr;29(4):239–242. doi: 10.1136/jmg.29.4.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kessler S., Field T., Worth L., Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet. 1987 Feb;26(2):259–270. doi: 10.1002/ajmg.1320260204. [DOI] [PubMed] [Google Scholar]
  10. Kremer B., Goldberg P., Andrew S. E., Theilmann J., Telenius H., Zeisler J., Squitieri F., Lin B., Bassett A., Almqvist E. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994 May 19;330(20):1401–1406. doi: 10.1056/NEJM199405193302001. [DOI] [PubMed] [Google Scholar]
  11. Maat-Kievit A., Vegter-Van Der Vlis M., Zoeteweij M., Losekoot M., van Haeringen A., Roos R. A. Predictive testing of 25 percent at-risk individuals for Huntington disease (1987-1997). Am J Med Genet. 1999 Dec 15;88(6):662–668. doi: 10.1002/(sici)1096-8628(19991215)88:6<662::aid-ajmg16>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  12. Maat-Kievit A., Vegter-van der Vlis M., Zoeteweij M., Losekoot M., van Haeringen A., Kanhai H., Roos R. Experience in prenatal testing for Huntington's disease in The Netherlands: procedures, results and guidelines (1987-1997). Prenat Diagn. 1999 May;19(5):450–457. [PubMed] [Google Scholar]
  13. Teltscher B., Polgar S. Objective knowledge about Huntington's disease and attitudes towards predictive tests of persons at risk. J Med Genet. 1981 Feb;18(1):31–39. doi: 10.1136/jmg.18.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tibben A., Frets P. G., van de Kamp J. J., Niermeijer M. F., Vegter-van der Vlis M., Roos R. A., van Ommen G. J., Duivenvoorden H. J., Verhage F. Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet. 1993 May 1;48(1):10–16. doi: 10.1002/ajmg.1320480105. [DOI] [PubMed] [Google Scholar]
  15. Tibben A., Timman R., Bannink E. C., Duivenvoorden H. J. Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol. 1997 Jan;16(1):20–35. doi: 10.1037//0278-6133.16.1.20. [DOI] [PubMed] [Google Scholar]
  16. Tyler A., Ball D., Craufurd D. Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium. BMJ. 1992 Jun 20;304(6842):1593–1596. doi: 10.1136/bmj.304.6842.1593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wiggins S., Whyte P., Huggins M., Adam S., Theilmann J., Bloch M., Sheps S. B., Schechter M. T., Hayden M. R. The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med. 1992 Nov 12;327(20):1401–1405. doi: 10.1056/NEJM199211123272001. [DOI] [PubMed] [Google Scholar]
  18. van der Steenstraten I. M., Tibben A., Roos R. A., van de Kamp J. J., Niermeijer M. F. Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet. 1994 Oct;55(4):618–625. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES